May 20, 2020 / 02:50PM GMT
Daniel Gregory Brennan - UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences
Good morning. This is Dan Brennan. I cover Diagnostics Tools and Pharma Services for UBS. And this is day 3 of the conference. Hopefully, you're enjoying it on the virtual conference, that is. Really pleased to be joined with me here on the virtual stage with the senior executive team from OraSure Technologies.
With me on the phone is Steve Tang, President and CEO; and Roberto Cuca. Roberto, if I mispronounce your last name, I apologize, the Chief Financial Officer.
I have a series of questions to go through, but please feel free to log into the webcast and send questions to me that way, and I'll try to get to those.
And I think Steve and Roberto are going to go through a bit of a prepared presentation, which will direct you to the right spot.
But -- with that, let me turn it over to them and say, again, welcome, guys.
Stephen S. Tang - OraSure Technologies, Inc. - President, CEO & Director
Dan,
OraSure Technologies Inc at UBS Global Healthcare Conference (Virtual) Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
